drugset / Trial / NCT04581265
Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.
NaSingle-groupOpen-labelTreatment
Summary
The purpose is to evaluate the effectiveness and safety of albumin-bound paclitaxel (nab-PTX), ifosfamide and cisplatin in the treatment of children patients with advanced, recurrent or refractory extracranial germ cell tumor.
Timeline
- Start
- 2020-11-10
- Primary completion
- 2023-11-10
- Completion
- 2024-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 20 mg/m2 | Intravenous |
| Subject | Ifosfamide | Small molecule | 1200 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 270 mg/m2 | Intravenous |